Skip to main content
. 2019 Mar 18;12(6):871–879. doi: 10.1093/ckj/sfz021

Table 3.

Population characteristics according to serum PTH course between baseline and M12

Parameters Early control, N=275 Escape, N=112 Late control, N=75 Uncontrolled, N=139
Male (%) 167 (60.7) 62 (55.4) 42.0 (56) 84 (60.4)
Age, mean ± SE (years) (%) 65.7 ± 14.3 61.3 ± 15.6 62.5 ± 15.7 60.4 ± 17.2
 <40  6.9 10.7 9.3 13.7
 40–55 13.8 25.0 21.3 25.9
 55–70 34.5 33.9 38.7 28.1
 70–85 37.8 25.0 24.0 25.9
 ≥85 6.9 5.4 6.7 6.5
BMI, mean ± SD (kg/m²) 25.8 ± 5.3 24.7 ± 6.2 26.0 ± 5.1 25.0 ± 5.0
 Obese, n (%) 47 (18.5) 14 (13.1) 13 (18.6) 19 (14.0)
Diabetes mellitus, n (%) 68 (24.7) 32 (28.6) 22 (29.3) 30 (21.6)
Dialysis duration, mean ± SD (years) (%) 4.3 ± 5.7 3.8 ± 4.9 5.0 ± 7.2 4.5 ± 5.7
 0–1 29.5 28.6 34.7 33.8
 1–5 44.0 50.0 36.0 38.8
 >5 26.5 21.4 29.3 27.3
Biological data at baseline
Serum PTH, mean ± SD (pg/mL) 787 ± 315 946 ± 431 1040 ± 391 1140 ± 492
Serum PTH, pg/mL (%)
 <600 26.5 17.9 4.0 7.2
 600–1000 55.3 48.2 56.0 37.4
 ≥1000  18.2 33.9 40.0 55.4
Serum calcium, mean ± SD (mmol/L) 2.18 ± 0.20 2.21 ± 0.19 2.21 ± 0.19 2.22 ± 0.19
Serum phosphate, mean ± SD (mmol/L) 1.61 ± 0.55 1.65 ± 0.62 1.78 ± 0.61 1.80 ± 0.50

Percentages are based on the total number of patients in each column for whom the answer is available.